{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:36:39Z","timestamp":1790400999000,"version":"4.1.0"},"reference-count":69,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:p>Os produtos finais da glica\u00e7\u00e3o avan\u00e7ada (AGEs [do ingl\u00eas, Advanced Glycation End-products]) constituem uma classe de mol\u00e9culas heterog\u00eaneas formadas a partir de rea\u00e7\u00f5es aminocarbonilo de natureza n\u00e3o-enzim\u00e1tica, que ocorrem aceleradamente no estado hiperglic\u00eamico do diabetes. Considerados importantes mediadores patog\u00eanicos das complica\u00e7\u00f5es diab\u00e9ticas, os AGEs s\u00e3o capazes de modificar, irreversivelmente, as propriedades qu\u00edmicas e funcionais das mais diversas estruturas biol\u00f3gicas. Na presente revis\u00e3o, s\u00e3o apresentados os dados recentes da literatura que descrevem as vias de forma\u00e7\u00e3o de AGEs, seu metabolismo, os principais mecanismos de a\u00e7\u00e3o dessas subst\u00e2ncias no desencadeamento dos processos patol\u00f3gicos, bem como os m\u00e9todos de determina\u00e7\u00e3o de AGEs em amostras biol\u00f3gicas. Este artigo aponta, ainda, novas perspectivas de terapias anti-AGEs, a exemplo de estudos envolvendo a a\u00e7\u00e3o de compostos naturais dos alimentos, que podem oferecer potencial terap\u00eautico para os portadores de diabetes ou de outras patologias associadas ao ac\u00famulo degenerativo de AGEs.<\/jats:p>","DOI":"10.1590\/s0004-27302008000600005","type":"journal-article","created":{"date-parts":[[2008,9,29]],"date-time":"2008-09-29T14:04:22Z","timestamp":1222697062000},"page":"940-950","source":"Crossref","is-referenced-by-count":45,"title":["O papel dos produtos finais da glica\u00e7\u00e3o avan\u00e7ada (AGEs) no desencadeamento das complica\u00e7\u00f5es vasculares do diabetes"],"prefix":"10.1590","volume":"52","author":[{"given":"J\u00fania H. P.","family":"Barbosa","sequence":"first","affiliation":[{"name":"Universidade Federal de Alagoas, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana L.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Universidade Federal de Alagoas, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luci Tojal e","family":"Seara","sequence":"additional","affiliation":[{"name":"Universidade Federal de Alagoas, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","article-title":"Global and societal implications of the diabetes epidemic","author":"Zimmet P","year":"2001","journal-title":"Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee M","year":"2001","journal-title":"Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2337\/diaclin.21.4.186","article-title":"Glucose, advanced glycation end products, and diabetes complications: what is new and what works","volume":"21","author":"Peppa M","year":"2003","journal-title":"Clin Diabetes"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.33549\/physiolres.930430","article-title":"Advanced glycation end products and the progress of diabetic vascular complications","volume":"53","author":"Jakus V","year":"2004","journal-title":"Physiol Res","ISSN":"https:\/\/id.crossref.org\/issn\/0862-8408","issn-type":"print"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.diabres.2004.09.004","article-title":"Advanced glycation endproducts-role in pathology of diabetic complications","volume":"67","author":"Ahmed N","year":"2005","journal-title":"Diabetes Res Clin Pract","ISSN":"https:\/\/id.crossref.org\/issn\/0168-8227","issn-type":"print"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0008-6363(97)00233-2","article-title":"AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus: I. The AGE concept","volume":"37","author":"Bierhaus A","year":"1998","journal-title":"Cardiovasc Res","ISSN":"https:\/\/id.crossref.org\/issn\/0008-6363","issn-type":"print"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2003.08.014","article-title":"Intervention against the Maillard reaction in vivo","volume":"419","author":"Monnier VM","year":"2003","journal-title":"Arch Biochem Biophys","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9861","issn-type":"print"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2337\/dc05-2096","article-title":"Diabetes and glicoxidation end products","volume":"29","author":"Huebschmann AG","year":"2006","journal-title":"Diabetes Care","ISSN":"https:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0968-0896(02)00564-3","article-title":"The role of dicarbonyl compounds in non-enzimatic crosslinking: a structure-activity study","volume":"11","author":"Meade SJ","year":"2003","journal-title":"Bioorg Med Chem","ISSN":"https:\/\/id.crossref.org\/issn\/0968-0896","issn-type":"print"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.freeradbiomed.2005.06.018","article-title":"Oxidative stress and diabetic cardiovascular complications","volume":"40","author":"Jay D","year":"2006","journal-title":"Free Radic Biol Med","ISSN":"https:\/\/id.crossref.org\/issn\/0891-5849","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1196\/annals.1333.039","article-title":"Interplay between the maillard reaction and lipid peroxidation in biochemical systems","volume":"1043","author":"Hidalgo FJ","year":"2005","journal-title":"Ann N Y Acad Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0077-8923","issn-type":"print"},{"issue":"84","key":"ref12","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1046\/j.1523-1755.63.s84.16.x","article-title":"AGEs in food: do they play a role in uremia?","volume":"63","author":"Henle T","year":"2003","journal-title":"Kidney Int Suppl","ISSN":"https:\/\/id.crossref.org\/issn\/0098-6577","issn-type":"print"},{"issue":"4","key":"ref13","first-page":"123","article-title":"Below the radar: advanced glycation end products that detour \"around the side\". Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes?","volume":"26","author":"Forbes JM","year":"2005","journal-title":"Clin Biochem Rev","ISSN":"https:\/\/id.crossref.org\/issn\/0159-8090","issn-type":"print"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cccn.2005.03.032","article-title":"Glyco-oxidation in diabetes and related diseases","volume":"357","author":"Lapolla A","year":"2005","journal-title":"Clin Chim Acta","ISSN":"https:\/\/id.crossref.org\/issn\/0009-8981","issn-type":"print"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1464-5491.2003.00973.x","article-title":"Serum levels of low molecular weight advanced glycation end products in diabetic subjects","volume":"20","author":"Sharp PS","year":"2003","journal-title":"Diabet Med","ISSN":"https:\/\/id.crossref.org\/issn\/0742-3071","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1196\/annals.1333.002","article-title":"The discovery of glycated hemoglobin: a major event in the study of nonenzymatic chemistry in biological systems","volume":"1043","author":"Rahbar S","year":"2005","journal-title":"Ann N Y Acad Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0077-8923","issn-type":"print"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: A unifying mecanism","volume":"54","author":"Brownlee M","year":"2005","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.2337\/diabetes.52.9.2441","article-title":"Level of an advanced glycated end product is genetically determined: A study of normal twins","volume":"52","author":"Leslie RD","year":"2003","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1196\/annals.1333.051","article-title":"Advanced glycation in health and disease: Role of the modern environment","volume":"1043","author":"Vlassara H","year":"2005","journal-title":"Ann N Y Acad Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0077-8923","issn-type":"print"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.94.12.6474","article-title":"Orally absorbed reactive glycation products (glicotoxins): an environmental risk factor in diabetic nephropathy","volume":"94","author":"Koschinsky T","year":"1997","journal-title":"Proc Natl Acad Sci U S A","ISSN":"https:\/\/id.crossref.org\/issn\/0027-8424","issn-type":"print"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jada.2004.05.214","article-title":"Advanced glycoxidation end products in commonly consumed foods","volume":"104","author":"Goldberg T","year":"2004","journal-title":"J Am Diet Assoc","ISSN":"https:\/\/id.crossref.org\/issn\/0002-8223","issn-type":"print"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2796.2002.00932.x","article-title":"Diabetes and advanced glycation endproducts","volume":"251","author":"Vlassara H","year":"2002","journal-title":"J Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0954-6820","issn-type":"print"},{"issue":"25","key":"ref23","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1073\/pnas.94.25.13915","article-title":"Tobacco smoke is a source of toxic reactive glycation products","volume":"94","author":"Cerami C","year":"1997","journal-title":"Proc Natl Acad Sci U S A","ISSN":"https:\/\/id.crossref.org\/issn\/0027-8424","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/bst0311341","article-title":"The enzymatic defence against glycation in health, disease and therapeutics: a symposium to examine the concept","volume":"6","author":"Thornalley PJ","year":"2003","journal-title":"Biochem Soc Trans","ISSN":"https:\/\/id.crossref.org\/issn\/0300-5127","issn-type":"print"},{"issue":"4","key":"ref25","first-page":"232","article-title":"Glycoxidation: the menace of diabetes and aging","volume":"70","author":"Vlassara H","year":"2003","journal-title":"Mt Sinai J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0027-2507","issn-type":"print"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00403957","article-title":"Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells","volume":"39","author":"Gugliucci A","year":"1996","journal-title":"Diabetologia","ISSN":"https:\/\/id.crossref.org\/issn\/0012-186X","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1046\/j.1523-1755.63.s84.31.x","article-title":"Immunohistochemical detection of an AGE, a ligand of macrophage receptor, in peritoneum of CAPD pacients","volume":"84","author":"Nakamura S","year":"2003","journal-title":"Kidney Int Suppl","ISSN":"https:\/\/id.crossref.org\/issn\/0098-6577","issn-type":"print"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/BF03401963","article-title":"Lyzosyme enhances renal excretion of advanced glycation endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: a potential AGE sequestration therapy for diabetic nephropathy?","volume":"7","author":"Zheng F","year":"2001","journal-title":"Mol Med","ISSN":"https:\/\/id.crossref.org\/issn\/1076-1551","issn-type":"print"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.mehy.2004.02.042","article-title":"TAGE (toxics AGEs) hypothesis in various chronic diseases","volume":"63","author":"Takeuchi M","year":"2004","journal-title":"Med Hypotheses","ISSN":"https:\/\/id.crossref.org\/issn\/0306-9877","issn-type":"print"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/diabetes.50.5.1214","article-title":"Polymorphism screening of four genes encoding advanced glycation end-product putative receptors: association study with nephropathy in type 1 diabetic patients","volume":"50","author":"Poirier O","year":"2001","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: Sparking the development of diabetic vascular injury","volume":"114","author":"Goldin A","year":"2006","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"issue":"5","key":"ref32","first-page":"351","article-title":"RAGE on the toll road?","volume":"3","author":"Lin L","year":"2006","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1254\/jphs.CPJ04005X","article-title":"Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury","volume":"97","author":"Yonekura H","year":"2005","journal-title":"J Pharmacol Sci"},{"issue":"8","key":"ref34","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.2337\/db05-1375","article-title":"Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes","volume":"55","author":"Shoji T","year":"2006","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.2337\/db06-0221","article-title":"RAGE control of diabetic nephropathy in a mouse model: Effects of RAGE gene disruption and administration of low-molecular weight heparin","volume":"55","author":"Myint KM","year":"2006","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","article-title":"Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes","volume":"63","author":"Basta G","year":"2004","journal-title":"Cardiovasc Res","ISSN":"https:\/\/id.crossref.org\/issn\/0008-6363","issn-type":"print"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2337\/db05-1635","article-title":"Diabetic retinopathy: seeing beyond glucose-induced microvascular desease","volume":"55","author":"Antonetti DA","year":"2006","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1442-9071.2001.00409.x","article-title":"Pathogenesis and intervention strategies in diabetic retinopathy","volume":"29","author":"Yu DY","year":"2001","journal-title":"Clin Experiment Ophthalmol"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0886-3350(02)01841-2","article-title":"Increased levels of advanced glycation end products in human cataractous lenses","volume":"29","author":"Franke S","year":"2003","journal-title":"J Cataract Refract Surg","ISSN":"https:\/\/id.crossref.org\/issn\/0886-3350","issn-type":"print"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1172\/JCI11771","volume":"108","author":"Yamamoto Y","year":"2001","journal-title":"J Clin Invest","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9738","issn-type":"print"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0026-0495(98)90362-6","article-title":"Patophysiology of diabetic nephropathy","volume":"47","author":"Cooper ME","year":"1998","journal-title":"Metabolism","ISSN":"https:\/\/id.crossref.org\/issn\/0026-0495","issn-type":"print"},{"key":"ref42","series-title":"Fisiopatologia","first-page":"896","volume-title":"Diabetes mellitus","author":"Guven S","year":"2004","edition":"6"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1172\/JCI18058","article-title":"Loss of pain perception in diabetes is dependent on a receptor of the imunoglobulin superfamily","volume":"114","author":"Bierhaus A","year":"2004","journal-title":"J Clin Invest","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9738","issn-type":"print"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJM199909023411006","article-title":"Cutaneous wound healing","volume":"341","author":"Singer A","year":"1999","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1196\/annals.1333.065","article-title":"Glycation products as markers and predictors of the progression of diabetic complications","volume":"1043","author":"Monnier VM","year":"2005","journal-title":"Ann N Y Acad Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0077-8923","issn-type":"print"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.2337\/diabetes.54.11.3103","article-title":"Glycation and carboxymethyllisyne levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes","volume":"54","author":"Genuth S","year":"2005","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1196\/annals.1333.036","article-title":"Simple noninvasive measurement of skin autofluorescence","volume":"1043","author":"Meerwaldt R","year":"2005","journal-title":"Ann N Y Acad Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0077-8923","issn-type":"print"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1196\/annals.1333.037","article-title":"Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease","volume":"1043","author":"Hartog JW","year":"2005","journal-title":"Ann N Y Acad Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0077-8923","issn-type":"print"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.2337\/dc06-2377","article-title":"Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C","volume":"30","author":"Maynard JD","year":"2007","journal-title":"Diabetes Care","ISSN":"https:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"issue":"7","key":"ref50","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.bjp.0706805","article-title":"Novel therapeutic strategies for reducing arterial stiffness","volume":"148","author":"McEniery CM","year":"2006","journal-title":"Br J Pharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1188","issn-type":"print"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0021-9150(03)00050-9","article-title":"Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice","volume":"168","author":"Lin R","year":"2003","journal-title":"Atherosclerosis","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9150","issn-type":"print"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/01.ASN.0000051593.41395.B9","article-title":"Restriction of dietary glicotoxins reduces excessive advanced glycation end products in renal failure patients","volume":"14","author":"Uribarri J","year":"2003","journal-title":"J Am Soc Nephrol","ISSN":"https:\/\/id.crossref.org\/issn\/1046-6673","issn-type":"print"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0021-9150(02)00008-4","article-title":"Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice","volume":"163","author":"Lin R","year":"2002","journal-title":"Atherosclerosis","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9150","issn-type":"print"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.2337\/diabetes.51.7.2082","article-title":"Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in db\/db mouse","volume":"51","author":"Hofmann S","year":"2002","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"issue":"8","key":"ref55","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.2337\/diabetes.54.8.2314","article-title":"Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake","volume":"54","author":"Sandu O","year":"2005","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"issue":"11","key":"ref56","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.2337\/diabetes.52.11.2805","article-title":"Adverse effects of dietary glycotoxins on wond healing in genetically diabetic mice","volume":"52","author":"Peppa M","year":"2003","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"issue":"6","key":"ref57","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2337\/diabetes.52.6.1441","article-title":"Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice","volume":"52","author":"Peppa M","year":"2003","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"issue":"24","key":"ref58","doi-asserted-by":"crossref","first-page":"15596","DOI":"10.1073\/pnas.242407999","article-title":"Inflamatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy","volume":"99","author":"Vlassara H","year":"2002","journal-title":"Proc Natl Acad Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0027-8424","issn-type":"print"},{"issue":"13-14","key":"ref59","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.drudis.2006.05.016","article-title":"Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases","volume":"11","author":"Reddy VP","year":"2006","journal-title":"Drug Discov Today"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"S796","DOI":"10.1093\/jn\/136.3.796S","article-title":"Antiglycation properties of aged garlic extract: possible role in prevention of diabetic complications","volume":"136","author":"Ahmad MS","year":"2006","journal-title":"J Nutr","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3166","issn-type":"print"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cbi.2006.05.020","article-title":"Green tea impedes dyslipidemia, lipid peroxidation, protein glycation and ameliorates Ca2+-ATPase and Na+\/K+-ATPase activity in the heart of streptozotocin-diabetic rats","volume":"162","author":"Babu PVA","year":"2006","journal-title":"Chem Biol Interact","ISSN":"https:\/\/id.crossref.org\/issn\/0009-2797","issn-type":"print"},{"issue":"5","key":"ref62","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.fitote.2005.03.021","article-title":"Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea","volume":"76","author":"Lunceford N","year":"2005","journal-title":"Fitoterapia","ISSN":"https:\/\/id.crossref.org\/issn\/0367-326X","issn-type":"print"},{"issue":"7","key":"ref63","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1590\/S0100-879X2003000700006","article-title":"Effect of an aqueous extract of Phaseolus vulgaris on the properties of tail tendon collagen of rats with streptozotocin-induced diabetes","volume":"36","author":"Pari L","year":"2003","journal-title":"Braz J Med Biol Res","ISSN":"https:\/\/id.crossref.org\/issn\/0100-879X","issn-type":"print"},{"issue":"2","key":"ref64","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/diabetes.54.2.517","article-title":"Paradoxical effects of green tea (camellia sinensis) and antioxidant vitamins in diabetic rats","volume":"54","author":"Mustata GT","year":"2005","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1196\/annals.1333.050","article-title":"Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia","volume":"1043","author":"Osawa T","year":"2005","journal-title":"Ann N Y Acad Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0077-8923","issn-type":"print"},{"issue":"8","key":"ref66","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.2337\/diabetes.52.8.2110","article-title":"Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine","volume":"52","author":"Babaei-Jadidi R","year":"2003","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"issue":"9","key":"ref67","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.2337\/dc06-0531","article-title":"Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes","volume":"29","author":"Stirban A","year":"2006","journal-title":"Diabetes Care","ISSN":"https:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"issue":"2","key":"ref68","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.mehy.2004.03.035","article-title":"The low-AGE content of low-fat vegan diets could benefit diabetics - though concurrent taurine supplementation may be needed to minimize endogenous AGE production","volume":"64","author":"McCarty MF","year":"2005","journal-title":"Med Hypotheses","ISSN":"https:\/\/id.crossref.org\/issn\/0306-9877","issn-type":"print"},{"issue":"11","key":"ref69","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.lfs.2004.05.002","article-title":"Anti-crosslinking properties of carnosine: significance of histidine","volume":"75","author":"Hobart LJ","year":"2004","journal-title":"Life Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0024-3205","issn-type":"print"}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v52n6\/05.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T03:40:33Z","timestamp":1709264433000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302008000600005&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0004-27302008000600005"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302008000600005","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}